Ontology highlight
ABSTRACT:
SUBMITTER: Liu LY
PROVIDER: S-EPMC6713025 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature
CNS oncology 20190601 2
<b>Aim:</b> Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). <b>Patients & methods:</b> We identified Bev-LTS as patients with post-Bev initiation survival times of ≥3 years among 1397 Bev treated recurrent glioma patients. <b>Results:</b> Among 962 grade-IV, 221 grade III, ...[more]